Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-10 · accession 0001209191-22-028725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-12 | 2022-05-10 | MIRM | Vig Pamela | Head of Research, Development | A - Grant | $13.57 | +807 | 21.2K | +4% | +$11.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-10 | A | A | 807 | $13.57 | 21,242 | D | — | — |